NCT01717898 2018-03-27A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate CancerUniversity of California, San FranciscoPhase 1/2 Terminated6 enrolled 5 charts